pentetic acid has been researched along with Peritoneal Neoplasms in 7 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Peritoneal carcinomatosis is a widespread dissemination of tumors throughout the peritoneal cavity." | 1.35 | Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells. ( Alke, A; Blechert, B; Bruchertseifer, F; Drecoll, E; Essler, M; Gaertner, FC; Miederer, M; Morgenstern, A; Müller, JM; Seidl, C; Senekowitsch-Schmidtke, R; Vallon, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drecoll, E | 1 |
| Gaertner, FC | 1 |
| Miederer, M | 1 |
| Blechert, B | 2 |
| Vallon, M | 1 |
| Müller, JM | 1 |
| Alke, A | 1 |
| Seidl, C | 2 |
| Bruchertseifer, F | 2 |
| Morgenstern, A | 2 |
| Senekowitsch-Schmidtke, R | 2 |
| Essler, M | 2 |
| Gärtner, FC | 1 |
| Neff, F | 1 |
| Low, RN | 3 |
| Carter, WD | 1 |
| Saleh, F | 1 |
| Sigeti, JS | 3 |
| Outwater, EK | 1 |
| Siegelman, ES | 1 |
| Wilson, KM | 1 |
| Mitchell, DG | 1 |
| Barone, RM | 1 |
| Lacey, C | 1 |
| Alzate, GD | 1 |
| Sebrechts, CP | 1 |
| Zhang, M | 1 |
| Yao, Z | 1 |
| Sakahara, H | 1 |
| Saga, T | 1 |
| Nakamoto, Y | 1 |
| Sato, N | 1 |
| Zhao, S | 1 |
| Nakada, H | 1 |
| Yamashina, I | 1 |
| Konishi, J | 1 |
7 other studies available for pentetic acid and Peritoneal Neoplasms
| Article | Year |
|---|---|
Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells.
Topics: Animals; Antineoplastic Agents; Bismuth; Cell Line, Tumor; Cell Nucleus; Drug Delivery Systems; Endo | 2009 |
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
Topics: Actinium; Animals; Bismuth; Cell Line, Tumor; Disease Models, Animal; Heterocyclic Compounds, 1-Ring | 2012 |
Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT.
Topics: Abdominal Neoplasms; Antibodies, Monoclonal; Contrast Media; Drug Combinations; Female; Fluorocarbon | 1995 |
MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Topics: Adult; Aged; Aged, 80 and over; Ascites; Contrast Media; Drug Combinations; False Positive Reactions | 1994 |
Benign and malignant gynecologic disease: clinical importance of fluid and peritoneal enhancement in the pelvis at MR imaging.
Topics: Ascitic Fluid; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Genital Diseases, Female; | 1996 |
Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
Topics: Administration, Oral; Barium Sulfate; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolin | 1997 |
Effect of administration route and dose of streptavidin or biotin on the tumor uptake of radioactivity in intraperitoneal tumor with multistep targeting.
Topics: Animals; Biotin; Humans; Iodine Radioisotopes; Isotope Labeling; Mice; Mice, Nude; Pentetic Acid; Pe | 1998 |